申请人:Pfizer Inc.
公开号:US04695571A1
公开(公告)日:1987-09-22
Tricyclic oxindole carboxamides, prepared by (a) reaction of an isocyanate with the basic ring system or (b) ammonolysis of a corresponding alkyl ester, are non-steroidal antiinflammatory agents useful in the treatment of rheumatoid arthritis.
三环氧吲哚羧酰胺,通过以下两种方法制备:(a)异氰酸酯与碱性环系统的反应,或者(b)对应的烷基酯的氨解反应。这些化合物是非类固醇抗炎药,可用于治疗类风湿性关节炎。